Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ruboxistaurin

Generic Name: Ruboxistaurin

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₈N_₄O_₃

CAS Number: 169939-94-0

Unique Ingredient Identifier: 721809WQCP

Overview

Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

Background

Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus

Phase 1

Completed

Posted: 2007/11/01

Sponsor:Chromaderm, Inc.

ID:NCT00552227

Effect of LY333531 on Vascular and Neural Functions

Phase 2

Completed

Posted: 2007/06/06

Sponsor:Chromaderm, Inc.

ID:NCT00482976

Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus

Phase 3

Completed

Posted: 2006/02/28

Sponsor:Chromaderm, Inc.

ID:NCT00297401

Treatment for Completers of the Study B7A-MC-MBCM

Phase 3

Completed

Posted: 2005/12/19

Sponsor:Chromaderm, Inc.

ID:NCT00266695

The Effect of Ruboxistaurin on Small Fiber Function

Phase 2

Completed

Posted: 2005/09/19

Sponsor:Chromaderm, Inc.

ID:NCT00190970

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy